Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
17-8-1|n/a,n/a|Sequence:1, Age:1200,Type:X-rays whole body,Quantity:2.4,Unit:grays,Application:External exposure, Remarks:age 12 to 72 months|5 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice 360d post TBI, different hematological parameters including determinations of GM-CFC in the bone marrow and blood and colony stimulating activity (CSA) and rhIL-6 levels in the serum; sequential studies over 1 year after the exposure|No information on individuals available for this study
17-8-1|n/a,n/a|Sequence:2, Age:1200,Type:none (controls),Quantity:,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:carrier autologous serum for 14 days starting one day after exposure|5 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice 360d post TBI, different hematological parameters including determinations of GM-CFC in the bone marrow and blood and colony stimulating activity (CSA) and rhIL-6 levels in the serum; sequential studies over 1 year after the exposure|No information on individuals available for this study
17-8-2|n/a,n/a|Sequence:1, Age:1200,Type:X-rays whole body,Quantity:2.4,Unit:grays,Application:External exposure, Remarks:age 12 to 72 months|4 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice 360d post TBI, different hematological parameters including determinations of GM-CFC in the bone marrow and blood and colony stimulating activity (CSA) and rhIL-6 levels in the serum; sequential studies over 1 year after the exposure|No information on individuals available for this study
17-8-2|n/a,n/a|Sequence:2, Age:1200,Type:interleukine-1,Quantity:18,Unit:milligrams per g animal,Application:Injection, subcutaneously, Remarks:rhIL-1 18 g/kg for 14 days starting 1 day after exposure|4 (0 in ERA)|Dog|Dog, Beagle|Both|Adult|Sacrifice 360d post TBI, different hematological parameters including determinations of GM-CFC in the bone marrow and blood and colony stimulating activity (CSA) and rhIL-6 levels in the serum; sequential studies over 1 year after the exposure|No information on individuals available for this study
		
